Egg Prices Surge How Everyday Essentials Are Driving UK Inflation AIPowered RealTime Feedback Reshapes Customer Experience Strategies US Official Highlights Japans Role in Fentanyl Smuggling Route Raising Alarms Over Transnational Crime AIDriven Job Applications Creating Doom Loop for Recruiters and Candidates Says Greenhouse CEO Putin and Xi Set to Discuss LongStalled Power of Siberia 2 Pipeline Amid Iran Conflicts Energy Shockwaves ValueQuests Sameer Shah Advocates Private Equity Approach to Public Markets for LongTerm Alpha Waste Connections Inc Q1 2026 Earnings EPS Beats Estimates Despite Flat Revenue Outlook MetLife MET Q1 2026 Earnings EPS Surpasses Estimates by 549 SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development QuickLogic Q1 2026 Earnings EPS Misses Estimates Amid Revenue Uncertainty CZNC Q1 2026 Earnings Massive EPS Miss Amid Surprising Stock Resilience HomeTrust Bancshares Q1 2026 Earnings Strong Earnings Beat Driven by Improved Net Interest Margin NOMADAR Corp NOMA Gains 286 as Stock Approaches Key Resistance Iveda Solutions Warrant IVDAW Holds Steady at 003 A Study in Stability Heron Therapeutics HRTX Slides to 086 as Selling Pressure Persists Circle Internet Group Inc CRCL Climbs 179 as Support Holds Near 111 Wetour Robotics WETO Slides 8 as Selling Pressure Intensifies Key Support Level in Focus Puig Shares Slide After Este Lauder Merger Talks Collapse European Markets Edge Higher BCML Q1 2026 Earnings Strong EPS Surprise Driven by Net Interest Income and Credit Quality Jack In The Box JACK Bounces from Support A Modest Gain Amidst Uncertainty Mountain Lake Acquisition Corp II Warrants MLAAW Holds Steady at 065 amid Quiet Trading AirJoule Technologies AIRJ Surges 13 Strong Momentum Meets Key Resistance at 503 Phoenix Asia Holdings PHOE Edges Higher as Key Resistance Nears Autodesk Gains 163 as Shares Test MidRange Resistance Levels VisionSys AI Inc VSA Surges Over 22 as Artificial Intelligence Sentiment Heats Up Itau Unibanco ITUB Pulls Back Support Levels in Focus After 175 Decline Trevi Therapeutics TRVI Shows Potential as Shares Climb Over 2